Cargando…

Investigating the Mechanisms of Jieduquyuziyin Prescription Improves Lupus Nephritis and Fibrosis via FXR in MRL/lpr Mice

Lupus nephritis (LN) is one of the most serious complications of systemic lupus erythematosus (SLE) and one of the leading causes of death. An alternative effective treatment to ameliorate and relieve LN and delay the process of renal tissue fibrosis is urgently needed in the clinical setting. Jiedu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jingqun, Ma, Qing, Sun, Qice, Luo, Qihan, Wang, Yiheng, Wang, Cheng, Zhu, Akao, Zhao, Lisha, Yin, Lu, Lou, Jiang, Dong, Yu, Qiu, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288302/ https://www.ncbi.nlm.nih.gov/pubmed/35855861 http://dx.doi.org/10.1155/2022/4301033

Ejemplares similares

Jieduquyuziyin Prescription-Treated Rat Serum Suppresses Activation of Peritoneal Macrophages in MRL/Lpr Lupus Mice by Inhibiting IRAK1 Signaling Pathway
por: Ji, Lina, et al.
Publicado: (2019)

ALW peptide ameliorates lupus nephritis in MRL/lpr mice
por: Wang, Huixia, et al.
Publicado: (2019)

Reduction of lupus nephritis in MRL/lpr mice by a bacterial superantigen treatment
Publicado: (1991)

Jieduquyuziyin Prescription Suppresses Inflammatory Activity of MRL/lpr Mice and Their Bone Marrow-Derived Macrophages via Inhibiting Expression of IRAK1-NF-κB Signaling Pathway
por: Ji, Lina, et al.
Publicado: (2020)

The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice
por: Shi, Yu, et al.
Publicado: (2019)

Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan
por: Keil, Andreas, et al.
Publicado: (2016)

Urine SERPINC1/ORM1 as biomarkers for early detection of lupus nephritis in MRL-lpr mice
por: Kim, Young-Eun, et al.
Publicado: (2023)

The protective capability of Hedyotis diffusa Willd on lupus nephritis by attenuating the IL-17 expression in MRL/lpr mice
por: Li, Ying, et al.
Publicado: (2022)

Enhanced expression of the soluble form of E-selectin attenuates progression of lupus nephritis and vasculitis in MRL/lpr mice
por: Nakatani, Kimihiko, et al.
Publicado: (2013)

Reduced receptor editing in lupus-prone MRL/lpr mice
por: Lamoureux, Jennifer L., et al.
Publicado: (2007)

Anti-RNA polymerase I antibodies in sera of MRL lpr/lpr and MRL +/+ autoimmune mice. Correlation of antibody production with delayed onset of lupus-like disease in MRL +/+ mice
Publicado: (1985)

Reno-protective effect and mechanism study of Huang Lian Jie Du Decoction on lupus nephritis MRL/lpr mice
por: Nie, Xiaoli, et al.
Publicado: (2016)

Intermittent Fasting Aggravates Lupus Nephritis through Increasing Survival and Autophagy of Antibody Secreting Cells in MRL/lpr Mice
por: Hong, Seung-Min, et al.
Publicado: (2020)

Murine lupus is neutrophil elastase-independent in the MRL.Fas(lpr) model
por: Gordon, Rachael A., et al.
Publicado: (2020)

Prevention of nephritis in major histocompatibility complex class II- deficient MRL-lpr mice
Publicado: (1994)

Prevention of Immune Nephritis by the Small Molecular Weight Immunomodulator Iguratimod in MRL/lpr Mice
por: Yan, Qingran, et al.
Publicado: (2014)

P-selectin blockade ameliorates lupus nephritis in MRL/lpr mice through improving renal hypoxia and evaluation using BOLD-MRI
por: Zhang, Liwen, et al.
Publicado: (2020)

Self-Reactivity and the Expression of Memory Markers Vary Independently in MRL-Mp+/+ and MRL-Mp-lpr/lpr Mice
por: Smyth, Lesley, et al.
Publicado: (1992)

Nitric oxide as an inflammatory mediator in autoimmune MRL-lpr/lpr mice.
por: Weinberg, J B
Publicado: (1998)

The MRL/lpr Mouse Strain as a Model for Neuropsychiatric Systemic Lupus Erythematosus
por: Gulinello, Maria, et al.
Publicado: (2011)

Fecal microbiota from MRL/lpr mice exacerbates pristane-induced lupus
por: Yi, Xiaoqing, et al.
Publicado: (2023)

Influence of thymic genotype on the systemic lupus erythematosus-like disease and T cell proliferation of MRL/Mp-lpr/lpr mice
Publicado: (1981)

Immunomodulatory effects of atorvastatin on MRL/lpr mice
por: Sun, Jing, et al.
Publicado: (2022)

Defective maintenance of T cell tolerance to a superantigen in MRL- lpr/lpr mice
Publicado: (1992)

Chlorogenic Acid Relieves the Lupus Erythematosus-like Skin Lesions and Arthritis in MRL/lpr Mice
por: Wang, Ruxuan, et al.
Publicado: (2022)

Lactobacillus spp. act in synergy to attenuate splenomegaly and lymphadenopathy in lupus-prone MRL/lpr mice
por: Cabana-Puig, Xavier, et al.
Publicado: (2022)

Prolactin Levels Correlate with Abnormal B Cell Maturation in MRL and MRL/lpr Mouse Models of Systemic Lupus Erythematosus-Like Disease
por: Legorreta-Haquet, Maria Victoria, et al.
Publicado: (2013)

Ets Family Transcription Factor Fli-1 Promotes Leukocyte Recruitment and Production of IL-17A in the MRL/Lpr Mouse Model of Lupus Nephritis
por: Sato, Shuzo, et al.
Publicado: (2020)

1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-κB and MAPK signalling pathways in MRL/lpr mice
por: Li, Xuewei, et al.
Publicado: (2022)

Rapamycin relieves lupus nephritis by regulating TIM-3 and CD4(+)CD25(+)Foxp3(+) Treg cells in an MRL/lpr mouse model
por: Gao, Yan-fang, et al.
Publicado: (2022)

Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice
por: Stock, Ariel D., et al.
Publicado: (2015)

Lupus pathogenesis and autoimmunity are exacerbated by high fat diet-induced obesity in MRL/lpr mice
por: Zhang, Xin, et al.
Publicado: (2023)

Naja naja atra Venom Protects against Manifestations of Systemic Lupus Erythematosus in MRL/lpr Mice
por: Zhu, Jiali, et al.
Publicado: (2014)

The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice
Publicado: (1988)

Early and Short-Term Interventions in the Gut Microbiota Affects Lupus Severity, Progression, and Treatment in MRL/lpr Mice
por: Zhang, Yun, et al.
Publicado: (2020)

TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous Lupus
por: Doerner, Jessica, et al.
Publicado: (2015)

Paradoxical Effects of All-Trans-Retinoic Acid on Lupus-Like Disease in the MRL/lpr Mouse Model
por: Liao, Xiaofeng, et al.
Publicado: (2015)

Jieduquyuzishen Prescription Attenuates Renal Fibrosis in MRL/lpr Mice via Inhibiting EMT and TGF-β1/Smad2/3 Pathway
por: Wu, Shan, et al.
Publicado: (2022)

MicroRNA-326 Upregulates B Cell Activity and Autoantibody Production in Lupus Disease of MRL/lpr Mice
por: Xia, Yuan, et al.
Publicado: (2018)

Complement Properdin Determines Disease Activity in MRL/lpr Mice
por: Alaridhee, Hasanain, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d1em1dpd2ggm2sdq367h33do07